In order to investigate the correlation between PDE2A expression and clinical pathological characteristics, we employed the UALCAN platform to analyze the variations in PDE2A expression across normal tissues and tumor tissues at different stages of cancer development. This evidence concerns the gene PDE2A and neoplasm.